Bloomage Biotechnology Co., Ltd

2024 Annual Performance Report of the Audit Committee of the Board of Directors

The Audit Committee of the Board of Directors of Bloomage Biotechnology Co., Ltd. (hereinafter referred to as the "Company") is diligent and actively carries out its work in accordance with the Code of Governance for Listed Companies, the Self-Regulatory Guidelines for Listed Companies on the Shanghai Stock Exchange No. 1 - Standardized Operation, the Articles of Association of Bloomage Biotechnology Co., Ltd. (hereinafter referred to as the "Articles of Association"), the Working Rules of the Audit Committee of Bloomage Biotechnology Co., Ltd. (hereinafter referred to as the "Working Rules of the Audit Committee") and other relevant regulations. Conscientiously perform the duties of the Audit Committee, and hereby report on the performance of the duties of the Audit Committee in 2024 as follows:

1. Basic information of the Audit Committee

In 2024, the Audit Committee of the second session of the Board of Directors of the Company will be composed of independent directors Mr. Chen Guanting, Ms. Wang Yingqian and Mr. Cao Fuguo, among which Mr. Chen Guanting, doctoral supervisor of Tsinghua University, certified public accountant and senior auditor, will serve as the chairman of the audit committee as an accounting professional.

2. Convening of the meeting of the Audit Committee

In FY2024, the Audit Committee held six meetings and was attended by all members. Specific

The situation is as follows:

Serial No. Session Date Deliberation Proposal

2nd Board Audit Committee February 2024

1 The first meeting of the committee in 2024 on the 28th "Proposal on Adjusting the Appointment of the Chief Financial Officer"

discuss

"Proposal on Reviewing the Annual Performance Report of the Audit Committee"

"Regarding the review of the company's performance of accounting firms in 2023

Proposal for job evaluation report》

The Audit Committee of the 2nd Board of Directors "On the Review of the Audit Committee's Opinion on the Accounting Firm 2023

Proposal for the April 2024 Monthly Report on the Performance of Supervisory Duties》

2 The second meeting of the committee in 2024 on the 15th, 2024 "Proposal on Reviewing the Company's Internal Control Evaluation Report"

On April 20, the "Proposal on the Sale of Assets to Shareholding Companies and Related Party Transactions".

Case》

"Proposal on the Review of the Company's 2023 Annual Report and its Summary".

Case》

"Proposal on the Company's 2023 Annual Financial Statements"

"Proposal on the Company's 2023 Profit Distribution Plan"

"Proposal on Change of Accounting Policies"

"Discussion on the Expected Daily Connected Transactions of the Company in 2024".

Case》

2nd Board Audit Committee April 2024

3 The third meeting of the committee in 2024 on the 22nd "Proposal on Reviewing the Company's First Quarter Report of 2024"

discuss

2nd Board Audit Committee May 2024

4 The 4th meeting of the committee in 2024 31 "Proposal on Reviewing the Selection and Appointment System of Accounting Firms"

discuss

Audit Committee of the Second Board of Directors August 2024 "On the Review of the Company's 2024 Semi-Annual Report and its Summary

5 12th of the 5th meeting of the committee in 2024

discuss

Audit Committee of the 2nd Board of Directors October 2024 "Proposal on Reviewing the Company's Third Quarter Report of 2024"

6 The 6th meeting of the committee in 2024 on the 24th "Proposal on the Renewal of the Company's 2024 Audit Institution"

discuss

3. Performance of duties of the Audit Committee in 2024

1. Supervise and evaluate external audit work

During the reporting period, the Audit Committee conducted several rounds of communication with the external auditor, Grant Thornton Certified Public Accountants (Special General Partnership), on the audit of the 2023 annual financial statements in an appropriate manner, including the scope of audit work, the audit business schedule, the important areas to be focused on by the audit, and the matters of concern recommended by the auditor to the management, and at the same time reviewed and approved the Company's 2023 annual report. Perform the audit duties diligently and responsibly, and complete the audit tasks well.

During the reporting period, the Audit Committee listened to the report of the Company's Audit and Supervision Center on the audit work in 2023, the audit plan in 2024, the key work in the first quarter of 2024, the key work in the first half of 2024, and the key work in the third quarter of 2024. It also puts forward opinions and suggestions on internal audit work to standardize the operation of internal audit. The Board is of the view that the Audit and Oversight Centre has performed its internal audit functions well and has not found any significant problems with the internal audit work.

3. Review the company's financial reports and disclosures

During the reporting period, the Audit Committee carefully reviewed the Company's audited financial report for 2023 and unaudited financial reports such as the first quarter report, semi-annual report and third quarter report for 2024, and believed that the Company's financial reports were true, accurate and complete, and objectively reflected the Company's operating conditions, operating results and cash flow.

4. Supervise and evaluate the company's internal control

During the reporting period, the Audit Committee reviewed and approved the "2023 Internal Control Evaluation Report of Bloomage Biotechnology Co., Ltd.", and listened to the report of the person in charge of the Company's Audit and Supervision Center on internal control, and found no major deficiencies related to the Company's internal control over financial reports and non-financial reports, and believed that the Company had established a relatively complete internal control system.

Fourth, the overall evaluation

During the reporting period, the Audit Committee performed its duties diligently and effectively in accordance with the Articles of Association and the Working Rules of the Audit Committee, and played an active and effective role in supervising and evaluating the work of external audit institutions, guiding internal audit work, reviewing the Company's financial reports, and supervising and evaluating the Company's internal control. In 2025, the Audit Committee will continue to fulfill its duties, maintain a prudent attitude, make use of its professional advantages, give full play to the guidance and supervision functions of the Audit Committee, continue to improve the standard operation level of the Company, and effectively safeguard the overall interests of the Company and the legitimate rights and interests of all shareholders.

Audit Committee of the Board of Directors of Bloomage Biotechnology Co., Ltd

April 9, 2025

(There is no text on this page, it is the signature page of the "2024 Annual Performance Report of the Audit Committee of the Second Board of Directors of Bloomage Biotechnology Co., Ltd.".)

Signature of the Member:

Chen Guanting

Wang Yingqian

Cao Fuguo

April 9, 2025